{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:52Z","timestamp":1761513832484,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clbc.2018.05.008","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T21:50:22Z","timestamp":1527889822000},"page":"e1217-e1227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations"],"prefix":"10.1016","volume":"18","author":[{"given":"Hitomi","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria Vanessa","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5891-8354","authenticated-orcid":false,"given":"Mai","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Okido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syoji","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Cancer Registry and Statistics","key":"10.1016\/j.clbc.2018.05.008_bib1"},{"key":"10.1016\/j.clbc.2018.05.008_bib2","unstructured":"Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. GeneReviews Initial posting September 4, 1998; updated December 15,\u00a02016."},{"key":"10.1016\/j.clbc.2018.05.008_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clbc.2018.05.008_bib4","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1200\/JCO.2010.33.6446","article-title":"Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women","volume":"29","author":"Lee","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","volume":"9","author":"Young","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2018.05.008_bib6","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","article-title":"Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer","volume":"26","author":"Atchley","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib7","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","article-title":"Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype","volume":"11","author":"Lakhani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib8","doi-asserted-by":"crossref","first-page":"R465","DOI":"10.1186\/bcr1025","article-title":"Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families","volume":"7","author":"Eerola","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jmedgenet-2011-100006","article-title":"Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer","volume":"48","author":"Evans","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2018.05.008_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","article-title":"Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study","volume":"134","author":"Fostira","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.05.008_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-012-2348-2","article-title":"Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer","volume":"137","author":"Rummel","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.05.008_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cge.12270","article-title":"Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis","volume":"85","author":"Tun","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.clbc.2018.05.008_bib16","doi-asserted-by":"crossref","first-page":"e38361","DOI":"10.1371\/journal.pone.0038361","article-title":"BRCA2 mutations and triple-negative breast cancer","volume":"7","author":"Meyer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.05.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u201cBRCAness\u201d in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev"},{"key":"10.1016\/j.clbc.2018.05.008_bib18","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr3049","article-title":"Quantitative copy number analysis by multiplex ligation-dependent probe amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness","volume":"13","author":"Lips","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib19","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/annonc\/mdq624","article-title":"An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients","volume":"22","author":"Vollebergh","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib20","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/bcr3655","article-title":"Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy","volume":"16","author":"Vollebergh","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib21","doi-asserted-by":"crossref","first-page":"e0167016","DOI":"10.1371\/journal.pone.0167016","article-title":"BRCAness as a biomarker for predicting prognosis and response to anthracycline-based adjuvant chemotherapy for patients with triple-negative breast cancer","volume":"11","author":"Mori","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.05.008_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2018.05.008_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","article-title":"Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009","volume":"20","author":"Goldhirsch","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib28","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","article-title":"Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005","volume":"16","author":"Goldhirsch","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2018.05.008_bib30","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":"Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification","volume":"30","author":"Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clbc.2018.05.008_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-008-0117-z","article-title":"Prediction of BRCA1-association in hereditary non-BRCA1\/2 breast carcinomas with array-CGH","volume":"116","author":"Joosse","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.05.008_bib32","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/bjc.2013.144","article-title":"Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers","volume":"108","author":"Lips","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2018.05.008_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103672","article-title":"Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer","volume":"53","author":"Kast","year":"2016","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2018.05.008_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cncr.26284","article-title":"Earlier age of onset of BRCA mutation-related cancers in subsequent generations","volume":"118","author":"Litton","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2018.05.008_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clbc.2014.08.003","article-title":"BRCAness predicts resistance to taxane-containing regimens in triple negative breast cancer during neoadjuvant chemotherapy","volume":"15","author":"Akashi-Tanaka","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2018.05.008_bib37","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cam4.648","article-title":"Family history of breast cancer and its association with disease severity and mortality","volume":"5","author":"Melvin","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2018.05.008_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-008-0255-3","article-title":"Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry","volume":"117","author":"Chang","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.05.008_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-006-9433-3","article-title":"Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study","volume":"105","author":"Figueiredo","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2018.05.008_bib40","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/bjs.9816","article-title":"Family history and outcome of young patients with breast cancer in the UK (POSH study)","volume":"102","author":"Eccles","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2018.05.008_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001648-199311000-00011","article-title":"Is survival among women diagnosed with breast cancer influenced by family history of breast cancer?","volume":"4","author":"Slattery","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.clbc.2018.05.008_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12885-018-4229-5","article-title":"Germline breast cancer susceptibility gene mutations and breast cancer outcomes","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918300223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918300223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:40Z","timestamp":1761513640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918300223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1526820918300223"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2018.05.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2018.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}